Raiffeisen Switzerland B.V. Share Price

Certificat

KUJRCH

CH1208660998

Real-time Bid/Ask 08:02:41 10/06/2024 BST
101.35 CHF / 102.16 CHF +0.41% Intraday chart for Raiffeisen Switzerland B.V.
Current month+0.26%
1 month+1.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
07/06/24 101.3 +0.10%
06/06/24 101.2 +0.02%
05/06/24 101.2 +0.06%
04/06/24 101.2 +0.07%
03/06/24 101.1 +0.01%

Delayed Quote Swiss Exchange

Last update June 07, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Raiffeisen Switzerland B.V.
KUJRCH
ISINCH1208660998
Date issued 09/09/2022
Strike 324.2 CHF
Maturity 09/09/2024 (91 Days)
Parity 0.32 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101.4 CHF
Lowest since issue 94.89 CHF
Spread 8.1 CHF
Spread %0.79%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
242.6 CHF
Average target price
277.5 CHF
Spread / Average Target
+14.40%
Consensus
  1. Stock Market
  2. Certificates
  3. KUJRCH Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW